U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H15NO3
Molecular Weight 185.2203
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ECGONINE

SMILES

CN1[C@H]2CC[C@@H]1[C@H]([C@@H](O)C2)C(O)=O

InChI

InChIKey=PHMBVCPLDPDESM-FKSUSPILSA-N
InChI=1S/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/t5-,6+,7-,8+/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H15NO3
Molecular Weight 185.2203
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.
1997 Sep
Ecgonine is an important marker for cocaine use in inadequately preserved specimens.
2001 Apr
In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte.
2001 Apr
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.
2001 Jun
2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies.
2001 Sep
Analysis of cocaine, benzoylecgonine, ecogonine methyl ester, and ecgonine by high-pressure liquid chromatography-API mass spectrometry and application to a short-term degradation study of cocaine in plasma.
2001 Sep
Synthesis and dopamine transporter binding of 2beta-isopropyl ester analogs of cocaine.
2002 Feb
Determination of the highest no-effect dose (HNED) and of the elimination pattern for cocaine in horses.
2002 Mar-Apr
Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
2004 Jan 1
Determination of cocaine, its metabolites, pyrolysis products, and ethanol adducts in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry.
2004 Jul 5
Gender differences in cocaine pharmacokinetics in CF-1 mice.
2005 Jan 15
Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry.
2005 Nov
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products.
2006 Feb 10
Bioanalytical procedures for determination of drugs of abuse in blood.
2007 Aug
Cocaine and metabolites urinary excretion after controlled smoked administration.
2007 Oct
Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium.
2009 May
Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine.
2010 Mar
Quantification of drugs of abuse in municipal wastewater via SPE and direct injection liquid chromatography mass spectrometry.
2010 Nov
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:46:18 GMT 2025
Edited
by admin
on Mon Mar 31 17:46:18 GMT 2025
Record UNII
DX2E9E17AV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IDS-NE-001
Preferred Name English
ECGONINE
MI   WHO-DD  
Common Name English
ECGONINE [MI]
Common Name English
3.BETA.-HYDROXY-1.ALPHA.H,5.ALPHA.H-TROPANE-2.BETA.-CARBOXYLIC ACID
Common Name English
3.BETA.-HYDROXY-2.BETA.-TROPANECARBOXYLIC ACID
Common Name English
Ecgonine [WHO-DD]
Common Name English
(1R,2R,3S,5S)-3-HYDROXY-8-METHYL-8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID
Systematic Name English
EKGONIN
Common Name English
Classification Tree Code System Code
DEA NO. 9180
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
207-565-4
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
DRUG BANK
DB01525
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
WIKIPEDIA
ECGONINE
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
MESH
C005617
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID701019899
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
PUBCHEM
91460
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
CHEBI
4743
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
CAS
481-37-8
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
FDA UNII
DX2E9E17AV
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
MERCK INDEX
m4810
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY Merck Index
EVMPD
SUB33203
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
SMS_ID
100000126157
Created by admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY